Slower aperiodic activity on magnetoencephalopathy may be associated with higher post-concussion symptomatology in high-school football players, according to new research to be presented at the Radiological Society of North America (RSNA) conference.
While it was previously dismissed as background noise, slower aperiodic activity on magnetoencephalopathy may emerge as a key clinical marker in the evaluation of concussions in high-school football players, according to new research that will be presented at the Radiological Society of North America (RSNA) conference.
For the study, researchers assessed resting state magnetoencephalopathy (MEG) studies performed prior to and after the season for 91 high school football players as well as data from Post-Concussive Symptom Inventory (PCSI) evaluations for these players.
The researchers found that increased aperiodic exponents in superior-frontal cortices were associated with concussions in the cohort, and that the slowing of aperiodic activity was associated with football players who had higher post-concussion symptomatology.
In a recent interview, lead study author Kevin C. Yu, B.S., noted the impact of magnetoencephalography in detecting these changes.
“Magnetoencephalography, or MEG, is just a fantastic tool for understanding signaling of the human brain. It's not only non-invasive, but it provides just a unique combination of spatial and temporal resolution. (This enables us to) see what's happening in the brain at very fast time scales, which is needed to measure arhythmic signaling … (and) also pinpoint where those patterns of brain activity are coming from. That is important, especially when you're trying to see the effects of concussion at (these) specific brain areas,” maintained Yu, a neuroscience student at the Wake Forest University School of Medicine in Winston-Salem, N.C.
(Editor’s note: For additional coverage of RSNA, click here.)
While Yu pointed out that aperiodic features were perceived as background noise on brain scans in the past and weren’t given much of a focus in the neurophysiology literature, there has been a renewed interest in aperiodic activity with respect to concussions.
“ … Providing further elucidation of what these signals might mean and how they change in terms of neurophysiology is important, and I'm really excited to see where this goes moving forward,” added Yu.
(Editor’s note: For related content, see “MRI Study Reveals Significant Brain Changes in Adolescent Football Players,” “MRI Reveals Impact of Repetitive Head Impacts in Young Players” and “New Magnetic Sensor Picks Up Weaker Brain Waves, Potentially Improving Diagnosis”)
For more insights from Mr. Yu, watch the video below.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.